The SURMOUNT-1 trial tested tirzepatide in 2,539 adults
Pharmacokinetic Parameters The elimination phase after the single NAC administration could not be defined for two Caucasian participants according to the established condition (quality of extrapolated pharmacokinetic parameters as demonstrated by a determination coefficient, R 2 1000 L), indicating that the drug was able to reach deep tissue compartments
Through advanced liposome encapsulation technology, nutrients are protected, stabilized, and efficiently transported into cells, resulting in significantly improved biological outcomes
doi: 10.3389/fnmol.2021.793004 Received 11 October 2021 Accepted 29 November 2021 Published 17 December 2021 Volume 14 - 2021 Edited by Inmaculada Segura, Ludwig Maximilian University of Munich, Germany Reviewed by Jong-Woo Sohn, Korea Advanced Institute of Science and Technology, South Korea
Patients with newly diagnosed thyroid or neck masses should be asked about the use of these medications